OraSure Technologies (FRA:EP3) Cash per Share: €1.99 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:EP3 OraSure Technologies Inc FRA:EP3
56 GF Score
Price €3.42
GF Value €1.72
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is OraSure Technologies Cash per Share?

OraSure Technologies FRA:EP3 -0.58% 56 Cash per Share is €1.99 as of Jun. 2026. GuruFocus rates FRA:EP3 with a GF Score™ of 56/100 and a GF Value™ of €1.72 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). OraSure Technologies's Cash per Share for the quarter that ended in Jun. 2026 was €1.99.

OraSure Technologies  (FRA:EP3) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

OraSure Technologies Cash per Share Related Terms

OraSure Technologies Cash per Share Historical Data

* Premium members only.

The historical data trend for OraSure Technologies's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OraSure Technologies Cash per Share Chart

OraSure Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.88 1.44 3.62 3.43 2.42

OraSure Technologies Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.76 2.55 2.42 2.21 1.99
FRA:EP3
56GF Score
OraSure Technologies Inc FRA:EP3
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OraSure Technologies Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

OraSure Technologies's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=170.183/70.39
=2.42

OraSure Technologies's Cash per Share for the quarter that ended in Jun. 2026 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=139.385/70.16
=1.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of €1.99 mean?
OraSure Technologies (FRA:EP3) has a Cash per Share of €1.99 as of Jun. 2026. Cash per share is the per-share value of a company's available cash. View historical data for OraSure Technologies and its competitors.
Is OraSure Technologies' Cash per Share too high?
OraSure Technologies' current Cash per Share is €1.99. Overall, OraSure Technologies has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OraSure Technologies' Cash per Share compare to SMTI and UTMD?
OraSure Technologies' Cash per Share of €1.99 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Medical Devices & Instruments company?
A good Cash per Share depends on the Medical Devices & Instruments industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for OraSure Technologies and its competitors. OraSure Technologies's current Cash per Share is €1.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OraSure Technologies stock overvalued right now?
Based on GuruFocus' analysis, OraSure Technologies (FRA:EP3) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.72, compared to a current price of €3.42 — trading 98.8% above its estimated fair value. The current Cash per Share is €1.99. OraSure Technologies' overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For OraSure Technologies (FRA:EP3), the current Cash per Share is €1.99 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OraSure Technologies (FRA:EP3) Overvalued in 2026?

Based on GuruFocus' analysis, OraSure Technologies stock appears to be overvalued. The current stock price of €3.42 is trading 98.8% above its estimated GF Value™ of €1.72. GuruFocus considers OraSure Technologies to be Significantly Overvalued.

Key valuation signals for FRA:EP3:

  • Cash per Share: €1.99
  • GF Value™: €1.72 vs. price of €3.42 (98.8% above fair value)
  • GF Score™: 56/100 with 2 warning signs

No single metric tells the full story. See the FRA:EP3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OraSure Technologies Business Description

Other Exchanges OSUR:USA
Address 220 East First Street, Bethlehem, PA, USA, 18015
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
56GF Score

Get the complete analysis for FRA:EP3

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.42
Price
€1.72
GF Value